Heart Beat: LDL-Lowering Reverses Coronary Artery Disease; How PA Affects the Heart; Accuracy of “Wearables” & A-Fib Examined

New LDL-Lowering Agent Reverses Coronary Artery Disease Adding the new PCSK9 inhibitor alirocumab (Praluent®) to high-intensity statin therapy after a recent heart attack helped reverse the amount of plaque in arteries throughout the heart and appeared to stabilize the remaining plaque, researchers reported online April 3 in the Journal of the American Medical Association. The […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access